O'Mullan Cathy, Doherty Maryanne, Coates Rosemary, Tilley P J Matt
Aust J Prim Health. 2015;21(3):305-9. doi: 10.1071/PY13172.
Sexual difficulties relating to selective serotonin reuptake inhibitor (SSRI) medication have an impact on quality of life and are a common cause for non-adherence to medication. While most research has focussed on the prevalence and treatment of sexual difficulties, little is known about how patients cope with the adverse sexual effects of SSRIs. This qualitative study, using Interpretive Phenomenological Analysis (IPA), investigated the experiences of 10 Australian women currently coping with the adverse sexual effects ofthis antidepressant by conducting semi-structured interviews. This paper presents one major theme from the study and reports the findings related to women's self-reported experiences of interacting with GPs in their search for answers and validation of their concerns. Findings from the study add to the current literature by providing an insight into how interactions with GPs impact on women's abilities to cope with adverse sexual effects. Empathic discussions and shared decision-making between GPs and women can provide the opportunity to improve the management of the adverse sexual effects of SSRIs and may lead to improved outcomes for women.
与选择性5-羟色胺再摄取抑制剂(SSRI)药物相关的性功能障碍会影响生活质量,并且是导致不坚持服药的常见原因。虽然大多数研究都集中在性功能障碍的患病率和治疗上,但对于患者如何应对SSRI的不良性影响却知之甚少。这项定性研究采用解释现象学分析(IPA)方法,通过进行半结构化访谈,调查了10名澳大利亚女性目前应对这种抗抑郁药不良性影响的经历。本文呈现了该研究的一个主要主题,并报告了与女性在寻求答案和确认自身担忧时与全科医生互动的自我报告经历相关的研究结果。该研究的结果通过深入了解与全科医生的互动如何影响女性应对不良性影响的能力,为当前文献增添了内容。全科医生与女性之间的共情讨论和共同决策可以为改善SSRI不良性影响的管理提供机会,并可能为女性带来更好的结果。